Anatomic Location of Primary Melanoma: Survival Differences and Sun Exposure

April 2019 in “ Journal of The American Academy of Dermatology ”

Matthew Howard, Edmund Wee, Rory Wolfe, Catriona McLean, John W. Kelly, Yue Pan

melanoma cutaneous invasive melanoma melanoma-specific survival MSS posterior scalp thighs forearms hands anterior upper arms sun exposure hazard ratio HR skin cancer melanoma survival sun-exposed skin high-risk melanoma site

Studysummary This study found that melanoma on the posterior scalp is associated with worse survival compared to other body sites, while sun-exposed areas showed better survival outcomes.

Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer

View this study on jaad.org →

Discuss this study in the Community →

Research cited in this study

3 / 3 results

research Scalp Melanoma: Distinctive High-Risk Clinical and Histological Features

37 citations , January 2016 in “Australasian Journal of Dermatology”

This study observed that scalp melanomas in older men often grow rapidly, appear without pigment, and have more aggressive features compared to other head and neck melanomas.

research Androgenetic Alopecia in Men Aged 40-69 Years: Prevalence and Risk Factors

155 citations , December 2003 in “British Journal of Dermatology”

In this study, the researchers did not confirm previously reported links between AGA and smoking or benign prostatic hypertrophy, but found potential associations with alcohol consumption and lean body mass at age 21 that merit further investigation.

research Androgenetic Alopecia: Pathogenesis and Potential for Therapy

174 citations , November 2002 in “Expert Reviews in Molecular Medicine”

This review discusses the genetic factors contributing to androgenetic alopecia and highlights the potential for developing more effective therapies based on recent discoveries, but reports no new clinical results.